Compare Johnson & Johnson (JNJ) vs SoFi Technologies Inc (SOFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs SoFi Technologies Inc — how do they compare? Johnson & Johnson trades at $261.41 (market cap $618.09B), while SoFi Technologies Inc trades at $15.77 (market cap $20.16B). The key difference: Johnson & Johnson is far larger — about 30.7× SoFi Technologies Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while SoFi Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and SoFi Technologies Inc for 60 Days on average.
| JNJ | SOFI | |
|---|---|---|
Market Cap | $618.09B | $20.16B |
Volume | 6,050,983 | 49,646,331 |
Sector | Health | Financials |
52-Week High | $278.43 | $32.21 |
52-Week Low | $186.00 | $15.15 |
Typical Hold Time | 129 Days | 60 Days |
Enterprise Value | $646.37B | $20.30B |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
SoFi Technologies trades at $15.80, up 0.89% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth from $2.6B in 2024 to $3.6B in 2025, though net income dipped to $481M. Analyst consensus is mixed with 37% buy ratings but a $21.58 price target suggesting 37% upside. Recent news highlights stablecoin initiatives and record loan originations amid sector volatility.
SoFi presents a growth story with expanding financial services but faces execution risks in a competitive fintech landscape. The stock's current valuation at 31.86 P/E reflects optimism about future profitability, though negative operating cash flows and rising yields create headwinds. Upside depends on sustained loan growth and successful monetization of new products like SoFiUSD.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →
